CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 1,280 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Shares withheld for taxes Chairman and CEO gave up 37,205 shares (to pay taxes)
- 4 Open-market buy Director bought 423 shares at an average $4.56 ($1,930)
- 4 Open-market buy Director bought 394 shares at an average $4.54 ($1,790)
- 4 Open-market buy Chairman and CEO bought 394 shares at an average $4.54 ($1,790)
- 4 Open-market buy Director bought 1,956 shares at an average $4.51 ($8,817)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,114 shares at an average $4.53 ($9,571)
- 4 Open-market buy Chief Financial Officer bought 3,800 shares at $2.35 ($8,930)
- 4 Open-market buy Director bought 284 shares at an average $2.65 ($753)
- 4 Open-market buy Director bought 882 shares at an average $2.72 ($2,402)
- 4 Open-market buy Director bought 395 shares at an average $2.75 ($1,086)
- 4 Open-market buy Chairman and CEO bought 395 shares at an average $2.75 ($1,086)
- 4 Open-market buy Director bought 2,045 shares at an average $2.74 ($5,605)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,485 shares at an average $2.74 ($6,803)
Page 10 of 26 · 512 filings